A UK government inquiry found that the administration under Boris Johnson wasted roughly £10 billion [1] on personal protective equipment (PPE) during the pandemic.

The findings highlight systemic failures in procurement and the use of political influence to bypass standard bidding processes. This waste occurred between 2020 and 2022, leaving taxpayers to fund substandard or unnecessary equipment while the national stockpile remained inadequate.

According to the report published Tuesday, the waste was driven largely by a "VIP lane" that granted preferential treatment to suppliers with political connections [3]. This system allowed the government to overpay favored firms for equipment that was sometimes unusable or unnecessary [3].

Baroness Hallett, the chair of the COVID inquiry, said, "It should have been obvious that giving favourable treatment to suppliers with connections to the Conservative government resulted in us paying more for kit than from normal suppliers."

The inquiry noted that the government failed to stress-test its procurement plans before the crisis hit [3]. This lack of preparation, combined with the preferential lane, resulted in the waste of almost £10 billion [2].

Former Prime Minister Boris Johnson (Conservative) responded to the report by defending his administration's actions. "I'm proud of the government's response to the Covid pandemic," Johnson said.

The report concludes that the UK's reliance on a small number of politically connected suppliers created a procurement environment prone to overpricing [3]. This occurred alongside a broader failure to maintain an adequate pre-pandemic stockpile, which forced the government into rushed, expensive contracts [3].

“The UK wasted almost £10 billion on PPE procurement.”

The findings suggest that political patronage overrode fiscal prudence and quality control during a national emergency. By prioritizing 'VIP' connections over competitive bidding, the UK government not only incurred a massive financial loss but also compromised the efficiency of its pandemic response, providing a cautionary example of the risks associated with non-transparent procurement in times of crisis.